1. Home
  2. DXCM vs LPLA Comparison

DXCM vs LPLA Comparison

Compare DXCM & LPLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • LPLA
  • Stock Information
  • Founded
  • DXCM 1999
  • LPLA 1989
  • Country
  • DXCM United States
  • LPLA United States
  • Employees
  • DXCM N/A
  • LPLA N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • LPLA Investment Bankers/Brokers/Service
  • Sector
  • DXCM Health Care
  • LPLA Finance
  • Exchange
  • DXCM Nasdaq
  • LPLA Nasdaq
  • Market Cap
  • DXCM 34.1B
  • LPLA 30.4B
  • IPO Year
  • DXCM 2005
  • LPLA 2010
  • Fundamental
  • Price
  • DXCM $80.75
  • LPLA $381.88
  • Analyst Decision
  • DXCM Strong Buy
  • LPLA Strong Buy
  • Analyst Count
  • DXCM 20
  • LPLA 14
  • Target Price
  • DXCM $98.50
  • LPLA $379.79
  • AVG Volume (30 Days)
  • DXCM 2.8M
  • LPLA 516.5K
  • Earning Date
  • DXCM 07-24-2025
  • LPLA 07-24-2025
  • Dividend Yield
  • DXCM N/A
  • LPLA 0.32%
  • EPS Growth
  • DXCM N/A
  • LPLA 9.05
  • EPS
  • DXCM 1.33
  • LPLA 14.44
  • Revenue
  • DXCM $4,148,000,000.00
  • LPLA $12,896,160,000.00
  • Revenue This Year
  • DXCM $16.74
  • LPLA $28.22
  • Revenue Next Year
  • DXCM $15.27
  • LPLA $15.04
  • P/E Ratio
  • DXCM $60.81
  • LPLA $26.27
  • Revenue Growth
  • DXCM 9.11
  • LPLA 25.70
  • 52 Week Low
  • DXCM $57.52
  • LPLA $187.19
  • 52 Week High
  • DXCM $117.49
  • LPLA $390.23
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 43.91
  • LPLA 57.15
  • Support Level
  • DXCM $80.23
  • LPLA $375.77
  • Resistance Level
  • DXCM $83.70
  • LPLA $384.56
  • Average True Range (ATR)
  • DXCM 1.88
  • LPLA 8.77
  • MACD
  • DXCM -0.90
  • LPLA -2.15
  • Stochastic Oscillator
  • DXCM 12.63
  • LPLA 59.14

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About LPLA LPL Financial Holdings Inc.

LPL Financial Holdings is an independent broker/dealer that provides a platform of proprietary technology, brokerage, and investment advisory services to financial advisors and institutions. As of the end of 2024, the company had over 29,000 advisors on its platform managing $1.7 trillion of client assets. The company doesn't have material operations outside the United States.

Share on Social Networks: